Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
01:45 | Best Growth Stocks To Buy And Watch: See Updates To IBD Watchlists | ||
01:45 | Alphabet Heads List Of 5 Stocks At All-Time High. Who's On The IBD 50, Other Premium Lists? | ||
00:45 | A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed | ||
Fr | Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom | ||
Fr | Stock Market Surge Prompts This Bullish Change; Fed Meeting, Key AI Stock Earnings Loom | ||
Fr | Why Position Size Was An Important Element Of Trade Risk On Dell | ||
Fr | IPO Stock Of The Week: Restaurant Leader First Watch Eyes Buy Trigger | ||
Fr | And Then There Were Six. Nvidia Still Among The 'Perfect' Stocks | ||
Fr | Is Amazon Stock A Buy With Q1 Report Ahead? | ||
Fr | Price Shock Worries Amid Middle East Conflict Lift Two Oil Stocks | ||
Fr | Stock Market History: Investor's Business Daily Across 40 Years Of Bull Markets And Market Crashes | ||
Fr | Cava, IBD Stock Of The Day, Surges Past Buy Point As Restaurants Come In Hot | ||
Fr | Microsoft, Google Reports Lift Nvidia, Super Micro, Other AI Hardware Makers | ||
Fr | Google Helps Lift Nasdaq As Microsoft, Amazon Lead Dow Jones | ||
Fr | Stock Market Forecast: AI Investing And 4 More Predictions For The Next Decade | ||
Fr | Meta Returns To Spending Mode. But Analysts Say 'This Time It's Different.' | ||
Fr | Healthy Grocery Stock And Venture Capital Stock Have This In Common | ||
Fr | IBD Live Q&A And Two Key Stock Lists For April 26, 2024 | ||
Fr | Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review | ||
Fr | Chip Gear Vendor KLA Tops March-Quarter Views As Business Stabilizes | ||
Fr | Sellers Lurk In Amazon Stock, Super Micro Computer Ahead Of Earnings | ||
Fr | Surging Alphabet Stock Leads Broad-Based Tech Rally As Market Stages Recovery | ||
Fr | ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes | ||
Fr | Skechers Poised For Breakout On 30% Earnings Jump, Hiked Outlook | ||
Fr | AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title |